FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ergocalciferol 250microgram tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (J M Loveridge Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Bell,Sons & Co (Druggists) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application 2 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (William Ransom & Son Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application 1.8 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application 450 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ascabiol Emulsion 25% (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (A A H Pharmaceuticals Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Thornton & Ross Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Unichem Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ascabiol Emulsion 25% (Aventis Pharma) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (William Ransom & Son Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (William Ransom & Son Plc) 2 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Bell,Sons & Co (Druggists) Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (J M Loveridge Plc) 450 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Thornton & Ross Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (A A H Pharmaceuticals Ltd) 2 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (J M Loveridge Plc) 1.8 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzyl benzoate 25% application (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (The Boots Company) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alphavase 2 tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Bell,Sons & Co (Druggists) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (Part VIIID Drug Tariff Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment 50 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alphavase 2 tablets (Ashbourne Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (A A H Pharmaceuticals Ltd) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Thornton & Ross Ltd) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Thornton & Ross Ltd) 50 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (Part VIIID Drug Tariff Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (The Boots Company) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prazosin 2mg tablets (IVAX Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Bell,Sons & Co (Druggists) Ltd) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Unichem Plc) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
UrgoTul Absorb Border dressing 15cm x 20cm (Urgo Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
UrgoTul Absorb Border dressing 15cm x 20cm (Urgo Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
UrgoTul Absorb Border dressing 15cm x 20cm (Urgo Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft polymer wound contact dressing 11cm x 11cm VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nystan 100,000units/gram cream (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul dressing 11cm x 11cm (Urgo Laboratories) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Urgotul Start dressing 11cm x 11cm (Urgo Laboratories) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nystatin 100,000units/g cream 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft polymer wound contact dressing 11cm x 11cm 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nystatin 100,000units/g cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft polymer wound contact dressing 11cm x 11cm 25 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nystatin 100,000units/g cream (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nystatin 100,000units/g cream (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul dressing 11cm x 11cm (Urgo Laboratories) 25 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Urgotul dressing 11cm x 11cm (Urgo Laboratories) 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nystan 100,000units/gram cream (Bristol-Myers Squibb Pharmaceuticals Limited) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul Start dressing 11cm x 11cm (Urgo Laboratories) 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely digitoxin 100 microgram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely streptomycin (as streptomycin sulfate) 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Domperidone 30mg suppositories 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptomycin 1g powder for solution for injection vials (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptomycin 1g powder for solution for injection vials (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Domperidone 30mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Domperidone 30mg suppositories (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Motilium 30mg suppositories (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptomycin 1g powder for solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptomycin 1g powder for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Domperidone 30mg suppositories (Special Order) 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Digitoxin 100microgram tablets (Unichem Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 59 of 86 Next End

This concept is not in any reference sets

Back to Start